시버스 (CBUS) 주가

시버스(CBUS)는 NAS에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $1.61 (-1.23%), 시가총액 $106.08M, 52주 범위 $1.16 ~ $4.05.

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.

핵심 지표

• 현재가: $1.61 (-1.23%)
• 시가총액: $106.08M
• 52주 최저~최고: $1.16 ~ $4.05
• 섹터: Healthcare
• 산업: Biotechnology
• 거래소: NAS

시버스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.

시버스 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 매수 (4.3 / 5)

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 5.05
• 순이익률: 0.00%

자주 묻는 질문